scispace - formally typeset
M

Mónica Fernández

Researcher at University of Alabama at Birmingham

Publications -  26
Citations -  1773

Mónica Fernández is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Lupus erythematosus & Cohort. The author has an hindex of 19, co-authored 26 publications receiving 1623 citations. Previous affiliations of Mónica Fernández include University of Texas Health Science Center at Houston.

Papers
More filters
Journal ArticleDOI

Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII).

TL;DR: JSLE patients were more commonly of African-American descent, were more likely to have renal and neurological involvements, and to accrue renal damage, and had lower levels of helplessness and scored higher in the physical component measure of the SF-36 than aSle patients.
Journal ArticleDOI

A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE.

TL;DR: Examining health disparities as a function of ethnicity using data from LUpus in LUMINA, a longitudinal study of patients with systemic lupus erythematosus, found environmental, socioeconomic/demographic, clinical, and genetic factors play an important role as determinants of the ethnic differences observed.
Journal ArticleDOI

Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort.

TL;DR: Poorer long-term prognosis among men with SLE appears to be decisively determined by their accelerated development of damage, particularly early in the course of the disease.
Journal ArticleDOI

Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time

TL;DR: Socioeconomic-demographic, ethnicity, health insurance, behavioural and psychological variables are important mediators of high levels of disease activity in SLE during its course and interventions aimed at modifiable factors may improve the outcomes of SLE.